GlycoBac provides assay services for Sf-rhabdovirus GlycoBac has developed a sensitive assay for infectious Sf-rhabdovirus particles using our proprietary Sf-RVN cell line. Contact us for additional information and pricing. GlycoBac partners with MilliporeSigma GlycoBac has partnered with MilliporeSigma to facilitate the distribution of our Sf-RVN cell line for commercial vaccine and gene therapy vector production. In addition to distributing Sf-RVN cells through a cGMP cell bank, MilliporeSigma will offer a chemically defined medium formulation specially designed for Sf-RVN cells. See the announcement from MilliporeSigma
The editors of Virology chose to highlight this study. In addition, we were invited to post a synopsis of our study on the Virology Highlights blog. We thank the editors for recognizing the value of our work! |
|